No antibiotics before prostate biopsy? new study checks safety
NCT ID NCT06359964
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether it is safe to skip antibiotics before a prostate biopsy. Researchers followed 1753 men who had a biopsy through the perineum (the area between the scrotum and anus). They compared infection rates in those who did not get antibiotics to existing data from patients who did. The goal was to see if avoiding antibiotics increases the risk of serious infections like sepsis or hospitalization.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could show that skipping antibiotics before prostate biopsy is safe, reducing antibiotic use and resistance.
- What could go wrong
- This is an observational study, not a randomized trial, so results may be less reliable. Infection risks without antibiotics could still be higher for some patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
1,753 people
The number who actually took part.
- Started
-
Aug 2024
- Finished
-
Mar 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * All consecutive patients in participating centres receiving transperineal USG-guided biopsy for any indication including: * Elevated PSA * Abnormal DRE * Follow-up biopsy in active surveillance * Suspicion of CAP recurrence after radiotherapy * Follow-up biopsy after focal therapy * Consenting to the study Exclusion Criteria: * Recent suspected UTI within 1 month * Recent culture proven bacteriuria within 1 month * History of recurrent UTI * Indwelling urinary catheter * Immunocompromised state * High risk of infective endocarditis (including prosthetic heart valve, congenital heart disease, or previous history of infective endocarditis * Incompetent or incapable of understanding the nature of the study or giving informed consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Prostate cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Prince of Wales Hospital
Shatin, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A scanner in the operating room could show surgeons exactly where prostate cancer remains
- New PET tracer aims to light up hidden cancer targets
- Can daily adaptive radiotherapy spare healthy tissue in prostate cancer?
- Can a radioactive tracer and MRI reveal prostate Cancer's true extent?
- Five-Fraction radiation plus hormone therapy tested against High-Risk prostate cancer
- Can a 10-Hour eating window fight cancer fatigue?